Effects of eugenol and ginger oil on adjuvant arthritis and the kallikreins in rats

Asia Pacific Journal of Pharmacology

Volumn 12, Issue 1-2, 1997, Pages 9-14

  Sharma, J N ^a   Ishak, F I ^a   Yusof, A P M ^a   Srivastava, K C ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Anti inflammatory effects; Eugenol; Ginger oil; Inflammation; Kallikrein Kinin system

Indexed keywords

EUGENOL; KALLIKREIN;

ADJUVANT ARTHRITIS; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; GINGER; IMMUNOHISTOCHEMISTRY; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SYNOVIUM;

EID: 0030800579     PISSN: 02179687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Mustafa T, Srivastava KC. Possible leads for arachidonic acid metabolism altering drugs from natural products. Journal of Drug Development 1990; 3: 47-60.
2. Opdyke DW. Monographs on fragrance raw materials. Food and Cosmetic Toxicology 1975; 13: 545-54.
3. Fotos PG, Woolverton CJ, Van dyke K, Powell RL. Effect of eugenol on polymorphonuclear cell chemotaxis and chemiluminescence. Journal of Dental Research 1987; 66: 774-7.
4. Fotos PF, Woolverton CH, Moka MJ, Mermigas ME. Effect of eugenol on prostaglandin E levels in polymorphonuclear cell and serum. Annals of Dentistry 1988; 47: 19-22.
5. Hume WR. Effect of eugenol on constrictor responses in blood vessels of the rabbit ear. Journal of Dental Research 1983; 62: 101-5.
6. Srivastava JC, Malhotra N. Characterization and effects of a component isolated from a common spice clove (Caryophylli flos) on platelet aggregation and eicosanoid production. Thrombotic and Haemorrhagic Disorders 1990; 1: 59-66.
7. Srivastava KC, Malhotra N. Acetyl eugenol, a component of doves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets. Prostaglandins, Leukotrienes and Essential Fatty Acid 1991; 42: 73-81.
8. Rasheed A, Leakeman G, Totte J, Vlietinck AJ, Herman AG. Eugenol and prostaglandin biosynthesis. New England Journal of Medicine 1984; 310: 50-1
9. Kiuchi F, Shibuya M, Sankawa U. Inhibition of prostaglandin biosynthesis from ginger. Chemical and Pharmaceutical Bulletin 1982; 30: 747-54
10. Flynn DL, Rafferty MF, Boctor AM. Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, Shogaol, capsaicin and related pungent compounds. Prostaglandins, Leukotrienes and Medicine 1986; 24: 195-8.
11. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Medical Hypotheses 1992; 39: 342-8.
12. Sharma JN. The role of kinin system in joint inflammatory disease. European Journal of Rheumatology and Inflammation 1991; 11: 30-6.
13. Sharma JN. The role of kallikrein-kinin system in joint inflammatory disease. Pharmacological Research 1991; 23: 105-12.
14. Sharma JN. Involvement of the kinin-forming system in physiopathology of rheumatoid inflammation. Agents and Actions 1992; 38 (Suppl. III): 343-61.
15. Sharma JN, Buchanan WW. Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Experimental Toxicologic Pathology 1994; 46: 421-33.
16. Sharma JN, Mohsin SSJ. The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system. Experimental Pathology 1990; 38: 73-96.
17. Newbould BB. Chemotherapy of arthritis induced in rats by Mycobacterial adjuvant. British Journal of Pharmacology 1963; 21: 127-36.
18. Sharma JN. Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzeneimittel Forschung (Drug Research) (Germany) 1977; 27: 1455-57.
19. Sharma JN, Zeittin IJ, Deodhar SD, Buchanan WW. Detection of kallikrein-like activity in inflamed synovial tissue. Archives of International Pharmacodynamics and Therapeutics 1983, 262: 279-86.
20. Amundsen EJ, Putter J, Friberger P, Knos M, Larsbraten M, Glaeson. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Advances in Experimental Medical & Biology 1979; 120A: 83-95
21. Yamaguchi Y, Tanaka Y, Yamada K, Brando Y, Kunitomo M Abnormal lipid metabolism in arthritic rats. Japanese Journal of Pharmacology 1989; 50: 337-86.
22. Mohr W, Wild A. Adjuvant arthritis. Arzeneimittel Forschung 1976; 26: 1860-66
23. Al-Habaubi HA, Bennett D, Sharma JN, Thomas GR, Zeitlin IJ. A Synovial amidase acting on tissue kallikrein-selective substrate in clinical and experimental arthritis. Advances in Experimental Medical & Biology 1986; 198B: 405-11.
24. Star MS, West GB. Bradykinin and oedema formation in heated paw of rats. British Journal of Pharmacology 1967; 31: 178-84.
25. Edery H, Lewis GP. Kinin-formating activity and histamine in lymph after tissue injury. Journal of Physiology (London) 1963; 169: 568-73.
26. Azuma Y, Ozasa N, Ueda Y, Takagi N. Pharmacological studies on the anti-inflammatory action of phenolic compounds. Journal of Dental Research 1986; 65: 53-6.
27. Sharma JN, Wirth KJ. Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins. General Pharmacology 1996; 27: 133-6.
28. Srivastava KC, Mustafa T, Ginger (Zingiber officinale) and rheumatic disorders. Medical Hypotheses 1989; 29: 25-8.